147 related articles for article (PubMed ID: 1332095)
1. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
[TBL] [Abstract][Full Text] [Related]
3. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
Siever LJ; Uhde TW
Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
[TBL] [Abstract][Full Text] [Related]
5. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients.
Trestman RL; Yehuda R; Coccaro E; Horvath T; Knott P; Gabriel S; Siever LJ
Biol Psychiatry; 1995 Apr; 37(7):448-56. PubMed ID: 7786958
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls.
Siever LJ; Uhde TW; Silberman EK; Jimerson DC; Aloi JA; Post RM; Murphy DL
Psychiatry Res; 1982 Apr; 6(2):171-83. PubMed ID: 6283576
[TBL] [Abstract][Full Text] [Related]
7. Platelet membrane alpha 2-adrenergic receptors in depression.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.
Charney DS; Heninger GR; Sternberg DE; Hafstad KM; Giddings S; Landis DH
Arch Gen Psychiatry; 1982 Mar; 39(3):290-4. PubMed ID: 6279050
[TBL] [Abstract][Full Text] [Related]
10. Hormonal responses to clonidine and urinary MHPG in delusional and nondelusional melancholic patients: a placebo-controlled study.
Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):77-81. PubMed ID: 1657199
[TBL] [Abstract][Full Text] [Related]
11. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
[TBL] [Abstract][Full Text] [Related]
12. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
[TBL] [Abstract][Full Text] [Related]
13. Indices of noradrenergic output in depression.
Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL
Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600
[TBL] [Abstract][Full Text] [Related]
14. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
[TBL] [Abstract][Full Text] [Related]
15. Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls.
Sternberg DE; Charney DS; Heninger GR; Leckman JF; Hafstad KM; Landis DH
Arch Gen Psychiatry; 1982 Mar; 39(3):285-9. PubMed ID: 6279049
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenoreceptor status in obsessive-compulsive disorder.
Lee MA; Cameron OG; Gurguis GN; Glitz D; Smith CB; Hariharan M; Abelson JL; Curtis GC
Biol Psychiatry; 1990 May; 27(10):1083-93. PubMed ID: 2160292
[TBL] [Abstract][Full Text] [Related]
17. Effects of clonidine on central and peripheral catecholamine metabolism.
Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ
Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.
Sevy S; Papadimitriou GN; Surmont DW; Goldman S; Mendlewicz J
Biol Psychiatry; 1989 Jan; 25(2):141-52. PubMed ID: 2539200
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
Azorin JM; Raucoules D; Valli M; Levy C; Lancon C; Luccioni JM; Tissot R
Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
[TBL] [Abstract][Full Text] [Related]
20. Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment.
Charney DS; Heninger GR; Sternberg DE
Br J Psychiatry; 1983 Mar; 142():265-75. PubMed ID: 6305451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
